Patent · US Active

Solid forms and combination compositions comprising a beta-lactamase inhibitor and uses thereof

US12187752B2 · kind B2 · utility

0Cited by

17References

15Claims

0Family size

Assignee

VENATORX PHARMACEUTICALS, INC. · US

Inventors

Christopher J. Burns · Vivonne Bay, AU
Daniel C. Pevear · Downingtown, US
Luigi XERRI · Wayne, US
Timothy Henkel · Berwyn, US
Daniel McGarry · King of Prussia, US
Lawrence ROSEN · Malvern, US
Gerald S. Brenner · Norristown, US
Jean-Baptiste Arlin · Amsterdam, NL
Ana Fernandez Casares · Amsterdam, NL

Key dates

Filing date	Sep 27, 2023
Grant date	Jan 7, 2025
Priority date	—
Expiry date	Sep 27, 2043

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K31/546
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Described herein are crystalline forms of (R)-3-(2-(trans-4-(2-aminoethylamino)cyclohexyl)acetamido)-2-hydroxy-3,4-dihydro-2H-benzo[e][1,2]oxaborinine-8-carboxylic acid. In some embodiments, the crystalline forms are formulated for treating a subject in need thereof with a bacterial infection.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.